Patents by Inventor Robinson Antonio Martins de OLIVEIRA

Robinson Antonio Martins de OLIVEIRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS OF PRODUCTION AND PURIFICATION OF HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF RECOMBINANT GLYCOPROTEIN HORMONES
    Publication number: 20240228571
    Abstract: Disclosed is a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombinant thyroid-stimulating hormone (r-TSH), the recombinant luteinizing hormone (r-LH), the luteinizing hormone and the recombinant follicle-stimulating hormone (r-FSH). In addition, the present disclosure relates to the recombinant glycoprotein hormones comprising the equine ? and ? subunits, inter alia, the ? subunit of mammals and equine ? subunit, where the two subunits are fused in a simple chain, and chain-modifying agents, which hormones are easier to purify, more homogeneous, easier to produce on an industrial scale without using animals, in comparison with the wild glycoprotein hormone.
    Type: Application
    Filed: September 29, 2023
    Publication date: July 11, 2024
    Inventors: Marcelo Dias BARUFFI, Camillo del Cistia ANDRADE, Rubens Eduardo da SILVA, Robinson Antonio Martins de OLIVEIRA, Daniel Roberto CALLEJON
  • PROCESS OF PRODUCTION AND PURIFICATION OF HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF RECOMBINANT GLYCOPROTEIN HORMONES
    Publication number: 20240132565
    Abstract: Disclosed is a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombinant thyroid-stimulating hormone (r-TSH), the recombinant luteinizing hormone (r-LH), the luteinizing hormone and the recombinant follicle-stimulating hormone (r-FSH). In addition, the present disclosure relates to the recombinant glycoprotein hormones comprising the equine ? and ? subunits, inter alia, the ? subunit of mammals and equine ? subunit, where the two subunits are fused in a simple chain, and chain-modifying agents, which hormones are easier to purify, more homogeneous, easier to produce on an industrial scale without using animals, in comparison with the wild glycoprotein hormone.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 25, 2024
    Inventors: Marcelo Dias BARUFFI, Camillo del Cistia ANDRADE, Rubens Eduardo da SILVA, Robinson Antonio Martins de OLIVEIRA, Daniel Roberto CALLEJON
  • METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES
    Publication number: 20220267401
    Abstract: Disclosed is a method for producing hybrid or non-hybrid recombinant glycoprotein hormones, for example the recombinant equine chorionic gonadotropin (r-eCG), the hybrid recombinant chorionic gonadotropin, the recombinant thyroid-stimulating hormone (r-TSH), the recombinant luteinising hormone (r-LH), the luteinising hormone and the recombinant follicle-stimulating hormone (r-FSH).
    Type: Application
    Filed: May 10, 2016
    Publication date: August 25, 2022
    Inventors: Marcelo Dias BARUFFI, Camillo del Cistia ANDRADE, Rubens Eduardo da SILVA, Robinson Antonio Martins de OLIVEIRA, Daniel Roberto CALLEJON